FDA places recall on Medtronic guidewires

Candace Stuart | | Cardiovascular Business | Interventional Cardiology

The FDA issued a Class I recall on Medtronic guidewires used in PCIs and in the placement of left ventricular leads for cardiac rhythm devices.

Minneapolis-based Medtronic is notifying hospitals and distributors that the coating on the surface of some models of guidewires may delaminate and detach. The company said it received some complaints, including one that involved patient injury. It advised customers to quarantine the recalled guidewires and return them to the company for replacement or credit.

The affected guidewires were manufactured after mid-April 2013 under the following product lines:

  • Cougar nitinol workhorse guidewire
  • Cougar steerable guidewire
  • Zinger stainless steel workhorse guidewire
  • Zinger steerable guidewire
  • Thunder extra-support guidewire
  • Thunder steerable guidewire
  • ProVia crossing guidewire
  • Attain Hybrid guidewire

Candace Stuart, Contributor

Related Content

Key takeaways from ACC.25: Advances in cardiovascular science
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
Bringing state-of-the-art healthcare to Florida heart patients
Cardiologists make case against routine interventions for asymptomatic severe AS
First comprehensive T-TEER resource examines best practices for tricuspid valve repair

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.